Immune-Onc Therapeutics
About:
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Website: http://www.immune-onc.com/
Twitter/X: ImmuneOnc
Top Investors: National Cancer Institute, Vivo Capital, Northern Light Venture Capital, Octagon Capital Advisors, BOCOM International
Description:
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
$140M
$1M to $10M
Palo Alto, California, United States
2016-01-01
info(AT)immuneonc.com
Charlene Liao, Guo Liang Yu
11-50
2023-01-05
Private
© 2025 bioDAO.ai